CELH
Celsius Holdings, Inc.
CELH has the edge over CHD overall, supported by stronger fundamentals and stronger valuation.
CHD
Church & Dwight Co., Inc.
CHD has lower modeled downside risk, despite its lower overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
CHD Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Unavailable | |
| Healthy |
CHD's profitability and balance sheet are currently healthy, and its revenue is stable. There isn't enough data to rate its cash flow.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH has the edge over CHD in the historical PE scenario, which offers more potential upside but is not a forecast.
CHD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $88.68 | -21% |
| Forward | 28x | $112 | — |
| Fair | 31x | $102 | -8.4% |
| Current | 34x | $112 | — |
| Expensive | 47x | $153 | +37% |
Historical ranges are pointers, not guarantees.
CHD's PE is in its expensive range at 34x. If earnings grow as analysts expect, today's price would be 28x next year's earnings, in its cheap range.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over CHD on the outlook, with more favorable revenue expectations.
CHD Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect CHD's earnings to grow and its profitability to improve, with its revenue holding steady.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
CHD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.98 | +23% |
| Q3 2026 | $3.25 | +2.2% |
| Q2 2026 | $3.11 | +47% |
| Q1 2026 | $3.04 | +30% |
| Q4 2025 | $3.02 | +27% |
| Q3 2025 | $3.18 | +42% |
| Q2 2025 | $2.12 | -35% |
| Q1 2025 | $2.33 | -26% |
| Q4 2024 | $2.37 | -22% |
CHD has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over CHD on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over CHD on profitability, with a higher operating margin.
CHD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.6B | +1% |
| Q2 2026 | $1.5B | +1.6% |
| Q1 2026 | $1.5B | +0.1% |
| Q4 2025 | $1.6B | +3.9% |
| Q3 2025 | $1.6B | +5% |
| Q2 2025 | $1.5B | -0.3% |
| Q1 2025 | $1.5B | -2.4% |
| Q4 2024 | $1.6B | +3.5% |
CHD's revenue grew through 2023 and has held roughly level since: $1.6B last quarter, up 1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 18% | +2.1 points |
| Q2 2026 | 18% | +0.7 points |
| Q1 2026 | 20% | -0.3 points |
| Q4 2025 | 16% | -0.1 points |
| Q3 2025 | 16% | +22 points |
| Q2 2025 | 17% | -4.9 points |
| Q1 2025 | 20% | -0.2 points |
| Q4 2024 | 16% | +2.1 points |
CHD's operating margin was 18% last quarter, up 2.1 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH has the stronger cash trend. Its trailing FCF is up 100% versus its history, compared with CHD at up 18%.
CHD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | $237.7M | +78% |
| Q3 2024 | $315.4M | +39% |
| Q2 2024 | $206.6M | +4.4% |
| Q1 2024 | $216.7M | -13% |
| Q4 2023 | $133.5M | -51% |
| Q3 2023 | $227.6M | +38% |
| Q2 2023 | $197.9M | +47% |
| Q1 2023 | $248.1M | +81% |
CHD's free cash flow has been positive every quarter for six years: $987M over the past year, up 13% from the year before.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has 255M diluted shares, down 1.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
CHD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +500K shares |
| 1 year | -1.9% | -4.5M shares |
| 3 years | -4% | -10M shares |
| 5 years | -4.4% | -11.1M shares |
| Available history | -5.3% | -13.4M shares |
CHD has the edge over CELH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $37.1M |
| Q4 2025 | $300M |
| Q3 2025 | $300M |
| Q4 2022 | — |
| Q4 2021 | $445.1M |
| Q4 2020 | $300M |
| Q3 2020 | — |
| Q2 2020 | — |
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over CHD on leverage, with a lower net debt burden relative to earnings.
CHD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.3x | Healthy |
| Q2 2026 | 1.5x | Healthy |
| Q1 2026 | 1.3x | Healthy |
| Q4 2025 | 1.4x | Healthy |
| Q3 2025 | 1.5x | Healthy |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | 1.1x | Healthy |
| Q4 2024 | 1.2x | Healthy |
CHD's net debt is about 1.3 years of its operating earnings (EBITDA), down from 1.5 years a year ago.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
CHD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.9 | Neutral |
| Stochastic | 80.0 | Neutral |
CHD's weekly RSI is 69 (neutral) and its Stochastic is 80 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
CHD PE vs Consumer Defensive Sector
| Metric | CHD | Sector median | Relative |
|---|---|---|---|
| PE | 34x | 19x | 76% above |
| PE % | 71 | 18 | 53 pts above |
CHD has the edge over CELH on valuation relative to its sector.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
CHD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $103.4 | 8.1% above |
| 20 week MA | $100.4 | 11% above |
| 50 week MA | $96.8 | 15% above |
| 100 week MA | $97.2 | 15% above |
| 200 week MA | $97.4 | 15% above |
CHD has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
CHD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $70.7 | $86.9 | +23% |
| 2021 | $86.9 | $99.5 | +15% |
| 2022 | $99.5 | $82.1 | -18% |
| 2023 | $82.1 | $94.6 | +15% |
| 2024 | $94.6 | $105.9 | +12% |
| 2025 | $105.9 | $85.4 | -19% |
| 2026 YTD | $85.4 | $111.7 | +31% |
CHD has the edge over CELH on returns for 2026, with the stronger performance.